Aldeyra Therapeutics (DE:137)
NASDAQ:137
Earnings Data
Report Date
Jul 31, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.09Last Year’s EPS
-0.14Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
DE:137 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:137 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 30, 2026 | €1.27 | €1.29 | +1.57% |
May 06, 2025 | €2.43 | €1.94 | -20.09% |
May 02, 2024 | €3.75 | €3.88 | +3.52% |
Mar 07, 2024 | €3.58 | €3.56 | -0.56% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Aldeyra Therapeutics (DE:137) report earnings?
Aldeyra Therapeutics (DE:137) is schdueled to report earning on Jul 31, 2026, Before Open (Confirmed).
What is Aldeyra Therapeutics (DE:137) earnings time?
Aldeyra Therapeutics (DE:137) earnings time is at Jul 31, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Aldeyra Therapeutics stock?
The P/E ratio of Aldeyra Therapeutics is N/A.
What is DE:137 EPS forecast?
DE:137 EPS forecast for the fiscal quarter 2026 (Q2) is -0.09.